Published in Heart on March 29, 2010
Secondary Prevention in Acute Coronary Syndromes: A CALIBER Study | NCT01162187
Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy Study. Circulation (2016) 1.42
Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization. Vasc Health Risk Manag (2010) 1.16
Current discharge management of acute coronary syndromes: data from the Rijnmond Collective Cardiology Research (CCR) study. Neth Heart J (2014) 0.96
Optimal combination secondary prevention drug treatment and stroke outcomes. Neurology (2014) 0.86
Long-term survival in patients with different combinations of evidence-based medications after incident acute myocardial infarction: results from the MONICA/KORA Myocardial Infarction Registry. Clin Res Cardiol (2014) 0.81
Comments on an acute myocardial infarction study. Heart (2010) 0.75
Almanac 2011: Acute Coronary Syndromes. The National Society Journals Present Selected Research that has Driven Recent Advances in Clinical Cardiology. Mater Sociomed (2011) 0.75
Improved survival of patients with coronary artery disease and low ejection fraction with ICD implantation versus conventional therapy in a real world survey. BMC Res Notes (2012) 0.75
Reasons for not meeting coronary artery disease targets of care in ambulatory practice. Perm J (2010) 0.75
Extent of ST-segment deviation in a single electrocardiogram lead 90 min after thrombolysis as a predictor of medium-term mortality in acute myocardial infarction. Lancet (2001) 2.39
Asthma is associated with single-nucleotide polymorphisms in ADAM33. Clin Exp Allergy (2004) 2.20
Risk of thromboembolic events in patients with atrial flutter. Am J Cardiol (1998) 2.19
Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogenomics (2001) 1.91
Impact of early perfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: retrospective analysis of four German multicenter studies. J Am Coll Cardiol (1993) 1.77
Ten novel 11q23 chromosomal partner sites. European 11q23 Workshop participants. Leukemia (1998) 1.67
Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator. J Am Coll Cardiol (1989) 1.66
Pharmacokinetics and fibrin specificity of alteplase during accelerated infusions in acute myocardial infarction. J Am Coll Cardiol (1992) 1.63
Effects of thrombolytic therapy in acute inferior myocardial infarction with or without right ventricular involvement. HIT-4 Trial Group. Hirudin for Improvement of Thrombolysis. J Am Coll Cardiol (1998) 1.63
Pseudoaneurysm after cardiac catheterization: therapeutic interventions and their sequelae: experience in 86 patients. Cathet Cardiovasc Diagn (1997) 1.62
Cardiac risk factors, medication, and recurrent clinical events after acute coronary disease; a prospective cohort study. Eur Heart J (2001) 1.62
Extent of early ST segment elevation resolution: a simple but strong predictor of outcome in patients with acute myocardial infarction. J Am Coll Cardiol (1994) 1.61
Frequency of complications of cardiopulmonary resuscitation after thrombolysis during acute myocardial infarction. Am J Cardiol (1992) 1.61
Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: results of the rt-PA-APSAC patency study (TAPS) J Am Coll Cardiol (1992) 1.50
[Paradoxical cerebral embolism during fibrinolysis therapy in deep vein thrombosis and pulmonary embolism]. Dtsch Med Wochenschr (1994) 1.50
Previous cytomegalovirus or Chlamydia pneumoniae infection and risk of restenosis after percutaneous transluminal coronary angioplasty. Lancet (1997) 1.48
Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarction. Eur Heart J (2001) 1.47
Influence of time to treatment on early infarct-related artery patency after different thrombolytic regimens. ALKK-Study Group. Am Heart J (1999) 1.47
Intravenous streptokinase in acute myocardial infarction (I.S.A.M.) trial: serial evaluation of left ventricular function up to 3 years after infarction estimated by radionuclide ventriculography. I.S.A.M. Study Group. J Am Coll Cardiol (1991) 1.44
Absorption and hemodynamic effects of airway administration of adrenaline in patients with severe cardiac disease. Ann Intern Med (2000) 1.44
The patient with acute myocardial infarction who does not receive reperfusion treatment. Heart (2001) 1.43
Differences in the chromosomal profile of AML-M0 versus AML-M1: response. Blood (1996) 1.42
The 60 Minutes Myocardial Infarction Project. Characteristics on admission and clinical outcome in patients with reinfarction compared to patients with a first infarction. Eur Heart J (1998) 1.42
Lack of association between raised serum Lp(a) concentration and unsuccessful thrombolysis after acute myocardial infarction. Lancet (1990) 1.41
Prospective cross-sectional study of haemostatic factors in patients with and without coronary artery disease. Blood Coagul Fibrinolysis (2002) 1.41
[Long-term therapy after an acute myocardial infarct]. Dtsch Med Wochenschr (1992) 1.39
Comparison of primary angioplasty with conservative therapy in patients with acute myocardial infarction and contraindications for thrombolytic therapy. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group. Catheter Cardiovasc Interv (1999) 1.39
[ACE inhibitor-associated interstitial lung infiltrates]. Dtsch Med Wochenschr (1995) 1.39
[Diagnosis of pulmonary embolism]. Dtsch Med Wochenschr (1996) 1.38
Leisure sport activity as a trigger for acute coronary events in men without known coronary artery disease : a single-center case study. Herz (2011) 1.38
[Prehospital thrombolytic therapy in acute myocardial infarction]. Anaesthesist (1997) 1.38
Molecular cytogenetic characterization of a critical region in bands 7q35-q36 commonly deleted in malignant myeloid disorders. Blood (1998) 1.36
Cardioversion of atrial fibrillation in the elderly. ALKK-Study Group. Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausaerzte. Am J Cardiol (1996) 1.33
"Real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multi-centre German Cypher Registry. Z Kardiol (2004) 1.28
Safety observations from the pilot phase of the randomized r-Hirudin for Improvement of Thrombolysis (HIT-III) study. A study of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK) Circulation (1994) 1.28
Clinical, hematological and cytogenetic characteristics of atypical chronic myeloid leukemia. Ann Oncol (2000) 1.23
Investigation of coronary venous anatomy by retrograde venography in patients with malignant ventricular tachycardia. Circulation (2001) 1.22
Electromagnetic interference in patients with implanted pacemakers or cardioverter-defibrillators. Heart (2001) 1.21
Loss of Thy-1 (CD90) antigen expression on mesenchymal stromal cells from hematologic malignancies is induced by in vitro angiogenic stimuli and is associated with peculiar functional and phenotypic characteristics. Cytotherapy (2008) 1.17
The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial. J Am Coll Cardiol (2001) 1.16
Ventricular arrhythmias in idiopathic dilated cardiomyopathy. Br Heart J (1984) 1.14
Transvenous biventricular defibrillation halves energy requirements in patients. Circulation (2001) 1.12
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells. Cytotherapy (2008) 1.11
Mammalian skeletal muscle: reduced chloride conductance in drug-induced myotonia and induction of myotonia by low-chloride solution. Naunyn Schmiedebergs Arch Pharmacol (1972) 1.10
[Policy paper to the cardiac re-sychronization therapy]. Z Kardiol (2003) 1.09
Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases. Intergruppo Italiano Linfomi. Blood (2000) 1.09
[The therapy of atrial fibrillation. Rhythm or rate control?]. Dtsch Med Wochenschr (1997) 1.07
Molecular analysis of 11q13 breakpoints in multiple myeloma. Blood (1999) 1.05
Presynaptic depolarization of cutaneous mechanoreceptor afferents after mechanical skin stimulation. Exp Brain Res (1967) 1.05
A prospective placebo-controlled double-blind multicenter trial of intravenous streptokinase in acute myocardial infarction (ISAM): long-term mortality and morbidity. J Am Coll Cardiol (1987) 1.05
Characteristics, management modalities and outcome in chronic systolic heart failure patients treated in tertiary care centers: results from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registry. Clin Res Cardiol (2014) 1.04
Acute myocardial infarction occurring in versus out of the hospital: patient characteristics and clinical outcome. Maximal Individual TheRapy in Acute Myocardial Infarction (MITRA) Study Group. J Am Coll Cardiol (2000) 1.03
Fine mapping and single nucleotide polymorphism association results of candidate genes for asthma and related phenotypes. Hum Mutat (2001) 1.03
Exercise testing provides additional prognostic information in angiographically defined subgroups of patients with coronary artery disease. Circulation (1983) 1.01
Serial exercise testing up to 6 years after coronary bypass surgery: behavior of exercise parameters in groups with different degrees of revascularization determined by postoperative angiography. Am J Cardiol (1983) 1.01
Worldwide utilization of implantable cardioverter/defibrillators now and in the future. Card Electrophysiol Rev (2003) 1.00
Impact of prehospital delay on mortality in patients with acute myocardial infarction treated with primary angioplasty and intravenous thrombolysis. Am Heart J (2001) 1.00
Acute and long-term effects of consecutive radiofrequency applications on conduction properties of the subeustachian isthmus in type I atrial flutter. J Cardiovasc Electrophysiol (1998) 0.99
A prospective survey of febrile events in hematological malignancies. Ann Hematol (2011) 0.99
Regulation of GluR2 promoter activity by neurotrophic factors via a neuron-restrictive silencer element. Eur J Neurosci (2000) 0.99
The Sirolimus-eluting coronary stent in daily routine practice in Germany: trends in indications over the years. Results from the prospective multi-centre German Cypher Stent Registry. Clin Res Cardiol (2007) 0.98
Comparison of metoprolol and sotalol in preventing ventricular tachyarrhythmias after the implantation of a cardioverter/defibrillator. Am J Cardiol (1998) 0.98
[Lead-related complications in 340 patients with an implantable cardiverter/defibrillator]. Z Kardiol (1999) 0.98
[Commentary on the guidelines the diagnosis and the therapy of syncope--the European Society of Cardiology 2001 and the update 2004]. Z Kardiol (2005) 0.95
[Guideline invasive electrophysiological diagnostics]. Clin Res Cardiol (2007) 0.94
Exercise tolerance and working capacity after valve replacement. J Heart Valve Dis (1992) 0.94
Effect of composition of experimental solutions on neuronal survival during rat brain slicing. Exp Neurol (1995) 0.94
Lysis of basilar artery occlusion with tissue plasminogen activator. Lancet (1987) 0.94
Exposure to myelotoxic agents and myelodysplasia: case-control study and correlation with clinicobiological findings. Br J Haematol (1998) 0.93
Atrial reentrant tachycardia after surgery for congenital heart disease: endocardial mapping and radiofrequency catheter ablation using a novel, noncontact mapping system. Circulation (2001) 0.93
Cytogenetic aspects of B-cell chronic lymphocytic leukemia: their correlation with clinical stage and different polyclonal mitogens. Cancer Genet Cytogenet (1987) 0.92
Angina intensity is not different in diabetic and non-diabetic patients with acute myocardial infarction. Z Kardiol (2003) 0.92
Change in quality of life in the year following cardiac rehabilitation. Qual Life Res (2004) 0.92
CIZ gene rearrangements in acute leukemia: report of a diagnostic FISH assay and clinical features of nine patients. Leukemia (2005) 0.92
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays. Leukemia (2011) 0.92
The 60 minutes myocardial infarction project. Treatment and clinical outcome of patients with acute myocardial infarction in Germany. Eur Heart J (1997) 0.92
Effect of hypoxia on the sinoatrial node, atrium, and atrioventricular node in the rabbit heart. Circ Res (1979) 0.92
Anticoagulation: the present and future. Clin Appl Thromb Hemost (2001) 0.91
Differential effects of sotalol and metoprolol on induction of paroxysmal supraventricular tachycardia. Am J Cardiol (1984) 0.91
[Medical guideline for the treatment of adults with congenital heart abnormalities of the German-Austrian-Swiss Cardiology Specialty Society]. Clin Res Cardiol (2008) 0.90
A randomized, double-blind study of certoparin vs. unfractionated heparin to prevent venous thromboembolic events in acutely ill, non-surgical patients: CERTIFY Study. J Thromb Haemost (2010) 0.90
Characterization of a recurrent translocation t(2;3)(p15-22;q26) occurring in acute myeloid leukaemia. Leukemia (2006) 0.90
Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype. Leukemia (2001) 0.90